Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)
CNY 10.24
(0.29%)
CNY 10.24
(0.29%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 80.87 Million CNY | -27.48% |
| 2022 | 111.51 Million CNY | 12.11% |
| 2021 | 99.47 Million CNY | 37.12% |
| 2020 | 72.54 Million CNY | 1.57% |
| 2019 | 71.42 Million CNY | 0.63% |
| 2018 | 70.97 Million CNY | 7.35% |
| 2017 | 66.11 Million CNY | 15.85% |
| 2016 | 57.06 Million CNY | 35.85% |
| 2015 | 42.01 Million CNY | 26.83% |
| 2014 | 33.12 Million CNY | 119.44% |
| 2013 | 15.09 Million CNY | -42.81% |
| 2012 | 26.39 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 15.57 Million CNY | 327.64% |
| 2024 Q2 | 14.76 Million CNY | -5.17% |
| 2024 Q3 | 30.66 Million CNY | 107.62% |
| 2023 FY | 80.87 Million CNY | -27.48% |
| 2023 Q2 | 21.23 Million CNY | -15.37% |
| 2023 Q3 | 41.38 Million CNY | 94.88% |
| 2023 Q4 | -6.84 Million CNY | -116.53% |
| 2023 Q1 | 25.09 Million CNY | 123.75% |
| 2022 Q3 | 47.43 Million CNY | 78.56% |
| 2022 Q2 | 26.56 Million CNY | -13.96% |
| 2022 Q1 | 30.87 Million CNY | 192.91% |
| 2022 FY | 111.51 Million CNY | 12.11% |
| 2022 Q4 | 11.21 Million CNY | -76.36% |
| 2021 Q4 | 10.54 Million CNY | -74.96% |
| 2021 Q1 | 25.36 Million CNY | 120.76% |
| 2021 FY | 99.47 Million CNY | 37.12% |
| 2021 Q2 | 21.47 Million CNY | -15.36% |
| 2021 Q3 | 42.09 Million CNY | 96.06% |
| 2020 Q2 | 22.09 Million CNY | 609.4% |
| 2020 Q3 | 35.85 Million CNY | 62.3% |
| 2020 FY | 72.54 Million CNY | 1.57% |
| 2020 Q1 | 3.11 Million CNY | 69.67% |
| 2020 Q4 | 11.49 Million CNY | -67.95% |
| 2019 Q3 | 34.56 Million CNY | 95.53% |
| 2019 Q2 | 17.67 Million CNY | 1.96% |
| 2019 Q1 | 17.33 Million CNY | 190.62% |
| 2019 FY | 71.42 Million CNY | 0.63% |
| 2019 Q4 | 1.83 Million CNY | -94.69% |
| 2018 Q4 | 5.96 Million CNY | -81.43% |
| 2018 Q1 | 17.12 Million CNY | 292.34% |
| 2018 FY | 70.97 Million CNY | 7.35% |
| 2018 Q2 | 15.75 Million CNY | -7.99% |
| 2018 Q3 | 32.12 Million CNY | 103.89% |
| 2017 Q1 | 15.39 Million CNY | 171.85% |
| 2017 FY | 66.11 Million CNY | 15.85% |
| 2017 Q4 | 4.36 Million CNY | -86.41% |
| 2017 Q3 | 32.11 Million CNY | 125.48% |
| 2017 Q2 | 14.24 Million CNY | -7.48% |
| 2016 FY | 57.06 Million CNY | 35.85% |
| 2016 Q2 | 12.76 Million CNY | 5.83% |
| 2016 Q3 | 26.57 Million CNY | 108.13% |
| 2016 Q1 | 12.06 Million CNY | 51.57% |
| 2016 Q4 | 5.66 Million CNY | -78.69% |
| 2015 Q4 | 7.95 Million CNY | 0.0% |
| 2015 Q2 | 13.04 Million CNY | -0.0% |
| 2015 Q1 | 13.04 Million CNY | 26.14% |
| 2015 FY | 42.01 Million CNY | 26.83% |
| 2015 Q3 | 7.95 Million CNY | -38.98% |
| 2014 Q1 | 6.22 Million CNY | 0.0% |
| 2014 Q2 | 6.22 Million CNY | -0.0% |
| 2014 FY | 33.12 Million CNY | 119.44% |
| 2014 Q3 | 10.34 Million CNY | 66.26% |
| 2014 Q4 | 10.34 Million CNY | 0.0% |
| 2013 FY | 15.09 Million CNY | -42.81% |
| 2012 FY | 26.39 Million CNY | 0.0% |